Experts discussed their recommendations for second-line treatment options for patients with DLBCL.
Cyrus Khan, MD
Advertisement
Hematologist, Allegheny Health Network Cancer Institute
Articles by Cyrus Khan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Crawford Strunk, MD, on the Importance of Palliative Care in Sickle Cell Disease
3
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
4
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
5
